Search
for
Sort by
Research 31–60 of 1000+
- Reporting on Adverse Clinical Events
- Cystitis Due to Cytoxan: Case Report
- Chemotherapy-Induced Alopecia
- Hair Texture Changes and Regeneration after Chemotherapy may Lead us to Treat Autoimmune Hair Loss
- Atypical bilateral hyperpigmented macules on the lower legs possibly due to cyclophosphamide.
- The Role of Platelet-Rich Plasma in the Prevention of Chemotherapy-Induced Alopecia
- Formononetin: A Pathway to Protect Neurons
- Protection Against Chemotherapy-Induced Alopecia
- A COMPREHENSIVE REVIEW ON PHARMACOLOGICAL POTENTIALS OF CAFFEINE
- Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models
- Care for alopecia during chemotherapy of cancer patients
- Chemotherapy in Gynecologic Malignancy
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- 1409 Temporary cell cycle arrest by ALRN-6924: A novel, p53-targeting strategy to protect human scalp hair follicles against cyclophosphamide-induced alopecia
- Hand-Foot and Stump Syndrome to Sorafenib
- Hair growth in vitro from histocultured skin
- Clinical Case Notes. Castleman's disease of the lacrimal gland
- Investigating drug induced alopecia
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- DRUG‐ASSOCIATED ALOPECIA
- 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D3 analogue in humans
- Drug-Induced Skin, Nail and Hair Disorders
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Drug-Induced Hair Loss and Hair Growth
- Drug-induced acne
- Topical use of systemic drugs in dermatology: A comprehensive review
- Clinical Development of Topoisomerase-Interactive Drugs
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries